Obbligazione Barclay PLC 5% ( US06738J4W17 ) in USD

Emittente Barclay PLC
Prezzo di mercato 100 USD  ▼ 
Paese  Regno Unito
Codice isin  US06738J4W17 ( in USD )
Tasso d'interesse 5% per anno ( pagato 2 volte l'anno)
Scadenza 23/12/2022 - Obbligazione è scaduto



Prospetto opuscolo dell'obbligazione Barclays PLC US06738J4W17 in USD 5%, scaduta


Importo minimo 1 000 USD
Importo totale 694 000 USD
Cusip 06738J4W1
Standard & Poor's ( S&P ) rating A ( Upper medium grade - Investment-grade )
Moody's rating A1 ( Upper medium grade - Investment-grade )
Descrizione dettagliata Barclays PLC è una banca multinazionale britannica che offre una vasta gamma di servizi finanziari a clienti privati, aziende e istituzioni in tutto il mondo.

The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06738J4W17, pays a coupon of 5% per year.
The coupons are paid 2 times per year and the Obbligazione maturity is 23/12/2022

The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06738J4W17, was rated A1 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency.

The Obbligazione issued by Barclay PLC ( United Kingdom ) , in USD, with the ISIN code US06738J4W17, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.







Pricing Supplement 12Y Step Up Fixed Note
Page 1 of 9
424B2 1 d424b2.htm PRICING SUPPLEMENT 12Y STEP UP FIXED NOTE
CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered

Maximum Aggregate Offering Price

Amount of Registration Fee(1)
Global Medium-Term Notes, Series A

$694,000

$49.48
(1) Calculated in accordance with Rule 457(r) of the Securities Act of 1933.
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 2 of 9

Pricing Supplement dated December 20, 2010
Filed Pursuant to Rule 424(b)(2)
(To Prospectus dated August 31, 2010 and
Registration No. 333-169119
the Prospectus Supplement dated August 31, 2010)

US $6
N
pbBotes
the c
Dec
US$
but
o
hold r1
the fie,r94,
, S
e
deceasrd
s i
emb
Decemb te000 STEP UP FIXED RATE
eries
r
excluding
will be eq
eneficial
regarding
ok-entry; A
20
Dece
23
ual
commencing on
t Interes
of thes t Original Is
worthiness
rincipal protecti o
, 20
excluding Dece
m
, 20 b
to: 6.
Pa
ed beneficial of Ba
10 Ma
000 thereafter.
er
21,
e Note2
next following Interest tur
Bu
3
s i,
Pn
the Survivor's 2
ymenta
owner of the N o
Transferable. sue D
n provided
i
sines
mber 23,
50% per te s
020, t
June 23, 2011
Dat
yme
owner at
any
Lis n
s,ti t a
rclays
ty Dath
e. E
leas
Option, te:
at ma
Day
e
and
we tur
e: D
:
t s
2019, th
en
Dati i

e
annum Inte
will NO
Bank PL
the interest rate per a
see "Des
ng: The
TES DUE December 23
Decembe
C.
New
interes
ding
e. The
x mont
calendar year;
Notest
on
hs r 23,
ty, depe
York
rate
interest rate
repay those
and · 2010 Principal
The Note

rest Payment
cription of
will no s are
nds on the
ecember 23, 2022
Lon
per annu
Da
ach subsequent Interes
final Interestm
nnum will be eq
tes:
the Maturity
t P
P
Notes
prior to the enot,
abi
CUS
e
pri
t be list I
don
per annum
will
ual
Da
rio
dat
the permitt r
e ei
P:

od
riod
ed 0
will
to: 5.

to
o n , 202
th
te. In
ed dol
Survivor's Opelr
lity of B
te
of the rd
a
6738
Euro
Monthly,ei
50% 2 Principa
Protect
r
J4
be equal t
p
the Ma
any U. ion
ectly
rclays
W1
O
o:
e
will begin
S. t
be equal on
will end on,
turi
quest.
ar amount
se o
Ba
IS
to:
r ann
butr
rest Period
tion" below.
u
Quarte: i
her (
r
ty Dat
The
B
curi l Amo
n
nk
5.00% l d

p
m ·
y,
u ie
of an s r
IN: Ui e
S
r

right
ties c
PLC
4.625%
Fo unt:
Percentage:
tly
to
067
ann
ness ,
su
, and include, a
a
per a
exclude, the US$694
n
r each
The initial In
th ob
tis
m · In
Semi-At
Day e
e
Mat
to exerci
individual
exchange oli
fy its
38J4W17
u
e following the d
se t
r
teres
riteh
exerci
Conv
q e,0
gat
num · Ft
yi io

Interest
sn 00 Is
If you hold the
o
p
nnually, n
obli
) Interest Rate: r e
se
ti of
ga
ri
Pao
rest Period
Date.
by
uotatio suer: Barclays B
Notes
an
Denomin
d
n sa
· For e
wiy to maturity,
y th
tions as
ti
co
Annual
ll
option wi
st ird pa
ach Inte
each Interest
ly,
Survivor
em. P
begin 's
ll be
on: Following, rt
e
subj
a holder of they,
restes
on, an
Opti a
riod
payable
yment Date for the
ct n
they come
ons: Minimum
i
on:
e N k
dn
d in
ath of the beneficial owner
to: PLC
you w
ue.
cl ill
den
comm
mmencing on or af
of t
otes
Unadjusted oe
For each Interest period commencin
Upo
· a n
hD
n
ude,
e Is
ci su
ay C e
Interest
minati
arrears on
the o Price:
receive
R
o
ev
Notes, at le
a
ns
in any calen
unt of
g on or after D
ter December
preceding InterestCo 100
ast
and any payment to be
US
ng on or aft
provi e
23, 2
Original Is
d
permitted dollar % Series
100%
mad
te Type:
ery 23rd of
ed
dar year. e J of
Fixed
Period commencing on or after
r Dece
021, t
sue D
request by the author
suchh
a
amount
R : Global
on the
a
e inN
te
te an
Notes
of tot
For additio
a t
ecember 23, 2020e
$1,000 and integr
the Original
d en
ized repres
we
l r
e e
x
onal
nvention: 30/360 Set Medium-
your principal,
Original T
Iss
d on,
Period and end on, but ex
entau
terest rate
ercib
cl r
e
, to but e
une and December,
u a
al multxt
ses
details d
mber 23, 2019, to but
cl
ude, T
e
Date
u
tive of t,derm
subject
per annu
the
he
acquired by to
s, including any
Date
iples of
to
ing
m
exclud
by all
tlement: DTC; :
e,
the

http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 3 of 9

Pric
all
Sec
this e
or
u
affili to
commis
a
riti P
s
complete
ates ubli
ions
es
pricing s c
portion
and
Any
may A
o
Er
u gent
from
f
se t t
xcha '
he
this sI
hese
upplement C
s
ngei ommission
su
C
epresentas er
pricin
b equal
commiss
ommis
tiong to
s
eing t s
us t
ions
he
upple
ed(
o
ion1)
1
ton
me
in Proceeds
45%
pay
or
contrary
nt
a in
m o
s
anyi
ar fs
s
m th
ellitat
a
ket te
cr o
ngeps
arket
es B
r arclays
rin
alecipal
conces
ecurti
riminalties
o
esale t
rans B
sions
c an
ffense
ransack
or
action P
amount
WLC
of
fees
ommiss
e
tionsm Per
the
to
ionay
in n
ot
h N
as
any ote
otes
hera
use d
pt
N hi100%
or
s
otes $14
ealers
prove
p d
rici 1
Tor
after t 4
50
he
ng 5%
per
disu
heir 98
$1
Notes 55
0
initia0
w
pplemel %
0
ill
sapproved
nt
sal T
of
in
e ota
notU l
be
the $69
principal
lis
these
i at
s
nless 4
ed
nitial
w000
mou
os
e n
n
al
orte$10
oa
an
ecuritiesy
oo
f
urr 0
nd
U
N 6
d 3
S $
mays
otes
agent 68
rI
i n3
ecura9
d
nfor 37
etain
etermined a
itiest
dit
ms (1)
lle
i or
hat t
on
you B
a arclays
Bp
hisa
ot ortion
xchang
p e
her o
ricwr
rclays
i C
q
ing
se apita
of
us
C t
o
intat
apitil
hes
al
the I
ecnc
onInc will
syste
upplement i
o m
sr ta receive
commission
Ne
onfirmation soor
ruthful
notherf osus
itherr
of e
the
our
ale
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 4 of 9
The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit liabilities of
Barclays Bank PLC and are not insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency of
the United States, the United Kingdom or any other jurisdiction.
Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-5 of the prospectus supplement and
"Selected Risk Factors" below. We urge you to consult your investment, legal, tax, accounting and other advisers and to invest in
the Notes only after you and your advisors have carefully considered the suitability of an investment in the Notes in light of your
particular circumstances.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this pricing
supplement relates. Before you invest, you should read the prospectus dated August 31, 2010, the prospectus supplement dated
August 31, 2010, and other documents Barclays Bank PLC has filed with the SEC for more complete information about Barclays
Bank PLC. and this offering. Buyers should rely upon this pricing supplement, the prospectus, the prospectus supplement, and
any relevant free writing prospectus for complete details. You may get these documents and other documents Barclays Bank PLC
has filed for free by visiting EDGAR on the SEC website at www.sec.gov, and you may also access the prospectus and prospectus
supplement through the links below:


·
Prospectus dated August 31, 2010:
http://www.sec.gov/Archives/edgar/data/312070/000119312510201448/df3asr.htm


·
Prospectus Supplement dated August 31, 2010:
http://www.sec.gov/Archives/edgar/data/312070/000119312510201604/d424b3.htm
Our Central Index Key, or CIK, on the SEC website is 1-10257.
Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you this pricing
supplement, the prospectus, the prospectus supplement and any relevant free writing prospectus if you request it by calling your
Barclays Capital Inc. sales representative, such dealer or 1-888-227-2275 (Extension 2-3430). A copy of the prospectus may be
obtained from Barclays Capital Inc., 745 Seventh Avenue--Attn: US InvSol Support, New York, NY 10019.
You may revoke your offer to purchase the Notes at any time prior to the time at which we accept such offer by notifying the applicable
agent. We reserve the right to change the terms of, or reject any offer to purchase the Notes prior to their issuance. In the event of any
changes to the terms of the Notes, we will notify you and you will be asked to accept such changes in connection with your purchase. You
may also choose to reject such changes in which case we may reject your offer to purchase.
As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 5 of 9
SELECTED RISK FACTORS
An investment in the Notes involves significant risks. You should read the risks summarized below in connection with, and the
risks summarized below are qualified by reference to, the risks described in more detail in the "Risk Factors" section beginning
on page S-5 of the prospectus supplement. We urge you to consult your investment, legal, tax, accounting and other advisers and
to invest in the Notes only after you and your advisors have carefully considered the suitability of an investment in the Notes in
light of your particular circumstances.

·
Issuer Credit Risk--The Notes are our unsecured debt obligations, and are not, either directly or indirectly, an obligation of
any third party. Any payment to be made on the Notes, including any principal protection provided at maturity, depends on our

ability to satisfy our obligations as they come due. As a result, the actual and perceived creditworthiness of Barclays Bank
PLC may affect the market value of the Notes and, in the event we were to default on our obligations, you may not receive the
principal protection or any other amounts owed to you under the terms of the Notes.

·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--Although you will not
receive less than the principal amount of the Notes if you hold the Notes to maturity, the Original Issue Price of the Notes
includes the agent's commission and the cost of hedging our obligations under the Notes through one or more of our affiliates.

As a result, assuming no change in market conditions or any other relevant factor, the price, if any, at which Barclays Capital
Inc. and other affiliates of Barclays Bank PLC will be willing to purchase Notes from you in secondary market transactions
may be lower than the Original Issue Price, and any sale prior to the Maturity Date could result in a substantial loss to you.

·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes, including

hedging our obligations under the Notes. In performing these duties, the economic interests of our affiliates of ours are
potentially adverse to your interests as an investor in the Notes.
In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale of the Notes
to certain of its clients. In doing so, Barclays Wealth will be acting as agent for Barclays Bank PLC and may receive
compensation from Barclays Bank PLC in the form of discounts and commissions. The role of Barclays Wealth as a provider
of certain services to such customers and as agent for Barclays Bank PLC in connection with the distribution of the Notes to
investors may create a potential conflict of interest, which may be adverse to such clients. Barclays Wealth is not acting as
your agent or investment adviser, and is not representing you in any capacity with respect to any purchase of Notes by you.
Barclays Wealth is acting solely as agent for Barclays Bank PLC. If you are considering whether to invest in the Notes through
Barclays Wealth, we strongly urge you to seek independent financial and investment advice to assess the merits of such
investment.

·
Lack of Liquidity--The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates of
Barclays Bank PLC intend to make a secondary market for the Notes but are not required to do so, and may discontinue any
such secondary market making at any time, without notice. Even if there is a secondary market, it may not provide enough

liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely to make a secondary market for the
Notes, the price at which you may be able to trade your Notes is likely to depend on the price, if any, at which Barclays Capital
Inc. and other affiliates of Barclays Bank PLC are willing to buy the Notes. The Notes are not designed to be short-term
trading instruments. Accordingly, you should be able and willing to hold your Notes to maturity.

·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes will be affected by a

number of economic and market factors that may either offset or magnify each other, including:


·
the time to maturity of the Notes;


·
interest and yield rates in the market generally;


·
a variety of economic, financial, political, regulatory or judicial events; and


·
our creditworthiness, including actual or anticipated downgrades in our credit ratings.

PS­1
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 6 of 9
DESCRIPTION OF SURVIVOR'S OPTION
Upon request by the authorized representative of the beneficial owner of the Notes, Barclays Bank PLC will repay those Notes prior to
the Maturity Date following the death of the beneficial owner of the Notes (the "Survivor's Option"), provided such Notes were
acquired by the deceased beneficial owner at least six months prior to the date of the request. Upon the valid exercise of the Survivor's
Option and the proper tender of the Notes for repayment, Barclays Bank PLC will repay such Notes, in whole or in part, at a price equal
to 100% of the principal amount of the deceased beneficial owner's beneficial interest in the Notes plus accrued and unpaid interest to the
date of repayment. For purposes of this section, a beneficial owner of Notes is a person who has the right, immediately prior to such
person's death, to receive the proceeds from the disposition of such Notes, as well as the right to receive payment of the principal of the
Notes.
To be valid, the Survivor's Option must be exercised by or on behalf of the person who has authority to act on behalf of the deceased
beneficial owner of the Notes under the laws of the applicable jurisdiction (including, without limitation, the personal representative of or
the executor of the estate of the deceased beneficial owner or the surviving joint owner with the deceased beneficial owner).
The death of a person holding a beneficial ownership interest in the Notes: (1) with any person in a joint tenancy with right of
survivorship; or (2) with his or her spouse in tenancy by the entirety, tenancy in common, as community property or in any other joint
ownership arrangement, will be deemed the death of a beneficial owner of those Notes, and the entire principal amount of the Notes held
in this manner will be subject to repayment by Barclays Bank PLC upon request. However, the death of a person holding a beneficial
ownership interest in Notes as tenant in common with a person other than his or her spouse will be deemed the death of a beneficial
owner only with respect to such deceased person's interest in the Notes, and only the deceased beneficial owner's percentage interest in
the principal amount of the Notes will be subject to repayment.
If the ownership interest in the Notes is held by a nominee for a beneficial owner or by a custodian under a Uniform Gifts to Minors Act
or Uniform Transfer to Minors Act, or by a trustee of a trust that is wholly revocable by the beneficial owner, or by a guardian or
committee for a beneficial owner, the death of the beneficial owner of the Notes will constitute death of the beneficial owner for purposes
of the Survivor's Option, if the beneficial ownership interest can be established to the satisfaction of Barclays Bank PLC. In these cases,
the death of the nominee, custodian, trustee, guardian or committee will not be deemed the death of the beneficial owner of the Notes for
purposes of the Survivor's Option.
Barclays Bank PLC has the discretionary right to limit the aggregate principal amount of the Notes as to which exercises of the Survivor's
Option will be accepted by it from all authorized representatives of deceased beneficial owners in any calendar year, to an amount equal
to 2.0% of the aggregate amount of the Notes, outstanding as of the end of the most recent calendar year.
Barclays Bank PLC also has the discretionary right to limit to $250,000 the aggregate principal amount of Notes as to which exercises of
the Survivor's Option will be accepted by Barclays Bank PLC from the authorized representative for any individual deceased beneficial
owner of such notes in any calendar year. In addition, Barclays Bank PLC will not permit the exercise of the Survivor's Option (a) for a
principal amount less than $1,000, or (b) if such exercise will result in a beneficial ownership interest in a note with a principal amount of
less than $1,000 outstanding.
An otherwise valid election to exercise the Survivor's Option may not be withdrawn. Elections to exercise the Survivor's Option will be
accepted in the order that they are received and approved by Barclays Bank PLC, except for any election the acceptance of which would
contravene any of the limitations described above. Notes accepted for repayment through the exercise of the Survivor's Option will be
repaid on the first Interest Payment Date that occurs 60 or more calendar days after the date of the acceptance and approval by Barclays
Bank PLC. Each tendered Note that is not accepted in any calendar year due to the application of any of the limitations described in the
preceding paragraph will be deemed to be tendered in the following calendar year in the order in which all such Notes were originally
tendered. If a Note tendered through a valid exercise of the Survivor's Option is not accepted by Barclays Bank PLC, the trustee, upon
receipt of a valid written instruction from Barclays Bank PLC or its agent, will deliver a notice to the registered holder that states the
reason that Note has not been accepted for repayment.
Because the Notes will be issued in book-entry form (except in very limited circumstances), DTC or its nominee will be treated as the
holder of the Notes, will be the only entity that receives notices from Barclays Bank PLC (or the trustee) and, on behalf of the deceased
beneficial owner's authorized representative, will be the only entity that can exercise the Survivor's Option for such Notes. To obtain
repayment of the Notes pursuant to exercise of the Survivor's Option, the deceased beneficial owner's authorized representative must
provide the following items to the broker or other entity through which the beneficial interest in the Notes is held by the deceased
beneficial owner:


·
appropriate evidence satisfactory to Barclays Bank PLC that:

(1)
the deceased was the beneficial owner of the Notes at the time of death and his or her interest in the Notes was acquired

by the deceased beneficial owner at least six months prior to the request for repayment,


(2)
the death of the beneficial owner has occurred and the date of death, and

PS­2
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 7 of 9


(3)
the representative has authority to act on behalf of the deceased beneficial owner;

·
if the beneficial interest in the Notes is held by a nominee or trustee of, custodian for, or other person in a similar capacity to,

the deceased beneficial owner, evidence satisfactory to Barclays Bank PLC from the nominee, trustee, custodian or similar
person attesting to the deceased's beneficial ownership of that Notes;

·
a written request for repayment signed by the authorized representative of the deceased beneficial owner with the signature
guaranteed by a firm that is a participant in the Security Transfer Agents Medallion Program, the New York Stock Exchange

Medallion Signature Program or the Stock Exchange Medallion Program (generally a member of a registered national
securities exchange, a member of the Financial Industry Regulatory Authority, or a commercial bank or trust company having
an office in the United States);

·
tax waivers and any other instruments or documents that Barclays Bank PLC reasonably requires in order to establish the

validity of the beneficial ownership of the Notes and the claimant's entitlement to payment; and

·
any additional information Barclays Bank PLC requires to evidence satisfaction of any conditions to the exercise of the

Survivor's Option or to document beneficial ownership or authority to make the election and to cause the repayment of the
Notes.
In turn, the broker or other entity will deliver each of these items, through the appropriate direct participant in DTC and the facilities of
DTC will deliver the Survivor's Option form of notice (the "Form of Notice"), to the trustee and to Barclays Bank PLC and will certify to
Barclays Bank PLC that the broker or other entity represents the deceased beneficial owner. The broker or other entity will be responsible
for disbursing payments received from the trustee, through the facilities of DTC, to the authorized representative.
During any time in which the Notes are not represented by a global note and are issued in definitive form:
· all references in this section to participants and DTC, including the DTC's governing rules, regulations and procedures, will be
deemed inapplicable;
· all determinations that the DTC participants are required to make as described in this section will be made by Barclays Bank PLC,
including, without limitation, determining whether the applicable decedent is in fact the beneficial owner of the interest in the Notes
to be redeemed or is in fact deceased and whether the representative is duly authorized to request redemption on behalf of the
applicable beneficial owner; and
· all redemption requests, to be effective, must:


·
be delivered by the representative to Barclays Bank PLC and to the trustee;


·
be made by completing the Form of Notice in accordance with the related instructions; and

·
be accompanied by, if applicable, a properly executed assignment or endorsement, in addition to all documents
that are otherwise required to accompany a redemption request. If the record holder of the Note is a nominee of

the deceased beneficial owner, a certificate or letter from the nominee attesting to the deceased's ownership of a
beneficial interest in the Note must also be delivered.
Barclays Bank PLC retains the right to limit the aggregate principal amount of Notes as to which exercises of the Survivor's Option will
be accepted from all authorized representatives of deceased beneficial owners and from the authorized representative for any individual
deceased beneficial owner in any one calendar year as described above. All other questions regarding the eligibility or validity of any
exercise of the Survivor's Option generally will be determined by Barclays Bank PLC, which determination will be final and binding on
all parties.
The Form of Notice may be obtained from Barclays Bank PLC, 745 Seventh Avenue, New York, NY 10019, Attention: US-Syndicate,
MTN Desk US, telephone: 212-412-1535.
UNITED STATES FEDERAL INCOME TAX TREATMENT
The following discussion supplements the discussion in the prospectus supplement under the heading "Certain U.S. Federal Income Tax
Considerations" and supersedes it to the extent inconsistent therewith. The following discussion (in conjunction with the discussion in the
prospectus supplement) summarizes certain of the material U.S. federal income tax consequences of the purchase, beneficial ownership,
and disposition of the Notes.

PS­3
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 8 of 9
We intend to treat the Notes as indebtedness for U.S. federal income tax purposes and any reports to the Internal Revenue Service (the
"IRS") and U.S. holders will be consistent with such treatment, and each holder will agree to treat the Notes as indebtedness for U.S.
federal income tax purposes. The discussion that follows is based on this approach.
A U.S. holder will be taxable on interest income equal to the minimum coupon amount that will be paid on the Notes (the "Minimum
Coupon Amount") when it is accrued or received in accordance with the U.S. Holder's normal method of tax accounting. The Notes will
be treated as having "original issue discount" ("OID") for federal income tax purposes in an amount equal to the excess of the aggregate
interest payments on the Notes over the aggregate Minimum Coupon Amount of the Notes, assuming they remain outstanding until their
maturity. You will be required to include OID in income on a constant yield basis during your ownership of the Notes. In certain years,
your taxable income in respect of the Notes will exceed the cash interest payments you receive. See "U.S. Federal Income Tax
Considerations--Original Issue Discount" in the prospectus supplement.
3.8% Medicare Tax On "Net Investment Income"
Beginning in 2013, U.S. holders that are individuals, estates, and certain trusts will be subject to an additional 3.8% tax on all or a portion
of their "net investment income," which may include the interest payments and any gain realized with respect to the Notes, to the extent
of their net investment income that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried
individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), or $125,000 for a married individual filing a
separate return. U.S. holders should consult their advisors with respect to their consequences with respect to the 3.8% Medicare tax.
Information Reporting
Holders that are individuals (and, to the extent provided in future regulations, entities) may be subject to certain foreign financial asset
reporting obligations with respect to their Notes if the aggregate value of their Notes and their other "specified foreign financial assets"
exceeds $50,000. Significant penalties can apply if a holder fails to disclose its specified foreign financial assets. This information
reporting requirement is generally applicable for taxable years beginning after March 18, 2010. We urge you to consult your tax advisor
with respect to this and other reporting obligations with respect to your Notes.
PROSPECTIVE PURCHASERS SHOULD CONSULT THEIR TAX ADVISORS AS TO THE FEDERAL, STATE, LOCAL, AND
OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF NOTES.
CERTAIN EMPLOYEE RETIREMENT INCOME SECURITY ACT CONSIDERATIONS
Your purchase of a Note in an Individual Retirement Account (an "IRA"), will be deemed to be a representation and warranty by you, as
a fiduciary of the IRA and also on behalf of the IRA, that (i) neither the issuer, the placement agent nor any of their respective affiliates
has or exercises any discretionary authority or control or acts in a fiduciary capacity with respect to the IRA assets used to purchase the
Note or renders investment advice (within the meaning of Section 3(21)(A)(ii) of the Employee Retirement Income Security Act
("ERISA")) with respect to any such IRA assets and (ii) in connection with the purchase of the Note, the IRA will pay no more than
"adequate consideration" (within the meaning of Section 408(b)(17) of ERISA) and in connection with any redemption of the Note
pursuant to its terms will receive at least adequate consideration, and, in making the foregoing representations and warranties, you have
(x) applied sound business principles in determining whether fair market value will be paid, and (y) made such determination acting in
good faith.
For additional ERISA considerations, see "Employee Retirement Income Security Act" in the prospectus supplement.
SUPPLEMENTAL PLAN OF DISTRIBUTION
We have agreed to sell to Barclays Capital Inc. (the "Agent"), and the Agent has agreed to purchase from us, the principal amount of the
Notes, and at the price, specified on the cover of this pricing supplement. The Agent is committed to take and pay for all of the Notes, if
any are taken.

PS­4
http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010


Pricing Supplement 12Y Step Up Fixed Note
Page 9 of 9

US$694,000
BARCLAYS BANK PLC
STEP UP FIXED RATE NOTES DUE DECEMBER 23, 2022
GLOBAL MEDIUM-TERM NOTES, SERIES A
(TO PROSPECTUS DATED AUGUST 31, 2010, AND THE
PROSPECTUS SUPPLEMENT DATED AUGUST 31, 2010)

http://www.sec.gov/Archives/edgar/data/312070/000119312510286697/d424b2.htm
12/22/2010